NDRM Neuroderm Ltd. - Ordinary Shares

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

  FORM 15

 

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

 

Commission File Number: 001-36737

 

NeuroDerm Ltd.

 

 

(Exact name of registrant as specified in its charter)

 

Ruhrberg Science Building

3 Pekeris St.

Rehovot 7670212, Israel

+972 (8) 946-2729l

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

 

Ordinary shares, par value NIS 0.01 per share

(Title of each class of securities covered by this Form)

 

None

(Titles of all other classes of securities for which a duty to file reports under Section 13(a) or 15(d) remains)

 

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

 

	Rule 12g-4(a)(1)	¨
	Rule 12g-4(a)(2)	¨
	Rule 12h-3(b)(1)(i)	x
	Rule 12h-3(b)(1)(ii)	¨
	Rule 15d-6	¨
	Rule 15d-22(b)	¨

 

Approximate number of holders of record as of the certificate or notice date: One (1)

 

Pursuant to the requirements of the Securities Exchange Act of 1934, NeuroDerm Ltd. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

 

				NeuroDerm Ltd.
Date: October 30, 2017				By:		/s/ Oded S. Lieberman
				Name:		Oded S. Lieberman
				Title:		Chief Executive Officer and Director